Your session is about to expire
← Back to Search
Embodied Conversational Agent for Cancer (ECA-PRO Aim 3 Trial)
ECA-PRO Aim 3 Trial Summary
This trial tests a computer character that talks to you like a person, to improve health communication & engagement for people with limited health literacy.
ECA-PRO Aim 3 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ECA-PRO Aim 3 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has enrollment for this trial commenced?
"According to clinicaltrials.gov, the initial posting for this trial was on April 1st of 2022 and its last update occured on July 6th 2023; thus, it is no longer actively recruiting candidates. Nevertheless, there are 543 other studies that may be looking for enrollees at present."
What results is this investigation attempting to obtain?
"This 6-week medical trial is designed to assess the efficacy of ECA-PRO as a tool for medication adherence in breast cancer patients. Secondary objectives include measuring fatigue, depression and anxiety levels through four items from PROMIS profile that participants will rate on a scale of 1-5 (1 representing never, 5 always). The data collection process will be done either with an ECA or REDCap system depending on the type of intervention received by each patient."
Share this study with friends
Copy Link
Messenger